Susmed News

Susmed: Notice of commencement of operation of our clinical trial system utilizing blockchain technology in doctor-led clinical trials at the National Center of Neurology and Psychiatry

Dec 25, 2024 14:30

Susmed: (Progress of disclosure matters) Notice regarding commencement of provision of integrated venous disease registries

Dec 11, 2024 14:30

Susmed: Articles of Incorporation 2024/09/27

Sep 27, 2024 15:59

Susmed: Independent Officer Notification Form

Sep 12, 2024 16:00

Susmed: Matters relating to business plans and growth potential

Sep 5, 2024 16:00

Susmed: Notice of approval application for partial changes in manufacturing and sales approval matters for the “SustMed Med CBT-i Insomnia Disorder App”

Aug 30, 2024 14:00

Susmed: Notice regarding transition to a company with an Audit and Supervisory Committee, executive personnel affairs, and partial changes to the Articles of Incorporation

Aug 27, 2024 18:00

Susmed: Withdrawal of the insurance application form for the “Sustained Med CBT-i Insomnia Disorder App” at the time of the Reiwa 6 medical fee revision

Jan 29, 2024 15:30

Susmed: About materials released yesterday from the Ministry of Health, Labor, and Welfare

Jan 16, 2024 07:30

Susmed: Notice of achievement of a milestone relating to an agreement relating to joint research, development, and sales with Kyorin Pharmaceutical

Nov 2, 2023 17:00

Susmed: Articles of Incorporation 2023/09/29

Sep 29, 2023 15:06

Susmed: Notice of conclusion of an agreement on joint research and development and sales with Aska Pharmaceutical Co., Ltd. regarding therapeutic applications in the field of obstetrics and gynecology

Sep 25, 2023 14:00

Susmed: Notice Concerning the Conclusion of a Basic Agreement to Promote Real World Data (RWD) Utilization of Medical Devices Using Blockchain Technology

Sep 20, 2023 16:00

Susmed: Matters relating to business plans and growth potential

Sep 7, 2023 16:00

Susmed: Notice regarding the resignation of a director

May 25, 2023 14:00

Susmed: Notice regarding the establishment of the Governance Committee

May 18, 2023 14:00

Susmed: Notice of the European Patent Office on Patent Evaluation, patents relating to applications for the treatment of insomnia

Feb 22, 2023 14:30

Susmed: Approval for the manufacture and sale of medical devices to support the application of patients and doctors in the treatment of insomnia

Feb 15, 2023 18:30

Susmed: Notice of recognition of the manufacture and sale of medical devices used in the treatment of insomnia at the planned medical device investigation meeting

Dec 20, 2022 07:30

Susmed Inc: Notice on the signing of contracts for joint research, development and sale of therapeutic applications in the field of otology

Nov 9, 2022 14:00